◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksEHC › Revenue

Encompass Health Corp (EHC) Revenue 2006–TTM

DATA UPDATED 2026-09-19

Encompass Health Corp annual revenue for fiscal TTM was $6.2 billion, an increase of 4.6% from $5.9 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

EHC Annual Revenue

Revenue (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$6.2B$5.9B$5.4B$4.8B$4.3B$4.0B$3.6B$4.6B$4.3B$3.9B$3.6B$3.1B$2.4B$2.2B$2.1B$2.0B$1.9B$1.9B$1.8B$1.7B$1.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EHC Quarterly Revenue

Revenue (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$1.6B$1.6B$1.5B$1.5B$1.5B$1.5B$1.4B$1.4B$1.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

More EHC metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All EHC financial statements → Interactive EHC charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.